ScienceDex / Researcher record
Deisher, Theresa
- Avm Biotechnology, LLC (no department on record)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
Start from a Word CV, PubMed IDs or ORCID.
- Early Career
NIH Funding · FY2023
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
View yearly values
| Fiscal year | Linked awards | Records | Rank |
|---|---|---|---|
| 2019 | $211,047 | 1 | #34,189 |
| 2022 | $2,066,925 | 3 | #3,438 |
| 2023 | $1,963,580 | 2 | #3,905 |
Award activity
Awards through the years
NIH award records listing this researcher in each fiscal year.
- FY20191 record
- FY20223 records
- FY2023 · selected2 records
Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.
Publications
Loading publications…
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2019 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2023 award records by amount
NIH award records listing Deisher, Theresa as a PI. Multi-PI records show the full award amount for context.
- 5R44CA272096-02R44Contact PIExpedited Expansion Cohort Clinical Trial for Relapsed/Refractory 'no-option' Non-Hodgkin's Lymphoma/Leukemia Patients$1Maward amount
- 5R44DK121634-03R44Contact PITargeted Lymphoablation as an alternative to HSCT to cure T1D$963.6Kaward amount
Award organization
Organizations that administered FY2023 awards listing Deisher, Theresa as a PI.
FY2023 award administered by Avm Biotechnology, LLC ().
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2019First NIH AwardAvm Biotechnology, LLC
- 2022$500K Cumulative Funding
- 2022$1M Cumulative Funding
- 2022$2M Cumulative Funding
- 2022Entered Top 50% NationallyRanked #3438
- 2022Entered Top 25% NationallyRanked #3438